… on molecules that are being used, either in preclinical or clinical studies, to treat spinal cord
injuries, such … of action of these molecules are discussed, considering traumatic spinal cord …

… Spinal cord injury (SCI) remains a severe condition with an extremely high disability rate.
The challenges of SCI repair include its complex pathological mechanisms and the difficulties …

… Recent experimental research to treat spinal cord injury (SCI) pain has greatly increased
our understanding of how such chronic pain might be modulated in the human population. …

… strategies, but many researchers employed other approaches to improve recovery after
SCI, including transplants of various types of cells or biomaterials, electrical and magnetic …

… Molecular approaches focus on the modulation of a specific secondary event to promote
neuroprotection or neuroregeneration. The analysis of each drug considered the …

… It remains to be tested whether such an approach will also successfully ameliorate deficits
after SCI. In summary, several different approaches that aim at preventing inflammation …

… Here, we summarize the major advances in identifying therapeutic approaches to SCI in
mammalians, including neuroprotection, CNS regeneration, remyelination, and neuroplasticity, …

… Current standard treatment modalities of the SCI … injury and provide limited recovery of lost
neurological functions. Stem Cell Therapy (SCT) represents an emerging treatment approach …

… ways to improve the unsatisfactory cellular and molecular … recovery in a rat model of cord
injury 15 . There may be a number of practical hurdles to clinical development of this molecule, …

… is on the potential use of antibodies, small molecules, peptides,neurotrophins, and enzymes
to neutralize axon growth inhibitors to foster axonregeneration after acute spinal cord injury. …